Comparative pharmacogenetic analysis of risk polymorphisms in Caucasian and Vietnamese children with acute lymphoblastic leukemia: prediction of therapeutic outcome?

No abstract is available for this paper.

• Publication year

  2015

• Venue

  British Journal of Clinical Pharmacology

• Publication date

  2015-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/bcp.12481PMID 25099492PMCID PMC4345953
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• R: A language and environment for statistical computing.

  2014cited by this paper
• Prevalence of TPMT and ITPA gene polymorphisms and effect on mercaptopurine dosage in Chilean children with acute lymphoblastic leukemia

  2014cited by this paper
• Association between methylenetetrahydrofolate reductase polymorphisms and the relapse of acute lymphoblastic leukemia: a meta-analysis

  2014cited by this paper
• Comparison of Long-term Outcome Between White and Vietnamese Children Treated for Acute Lymphoblastic Leukemia According to the FRALLE 2000 Protocol

  2014cited by this paper
• Methylenetetrahydrofolate reductase C677T and overall survival in pediatric acute lymphoblastic leukemia: a systematic review

  2014cited by this paper
• Association of cyclin D1 A870G polymorphism with two malignancies: acute lymphoblastic leukemia and breast cancer.

  2013cited by this paper
• A systematic review and meta-analysis of MTHFR polymorphisms in methotrexate toxicity prediction in pediatric acute lymphoblastic leukemia

  2012cited by this paper
• Impact of methylenetetrahydrofolate reductase (MTHFR) polymorphisms on methotrexate-induced toxicities in acute lymphoblastic leukemia: a meta-analysis

  2012cited by this paper
• Pharmacogenetic study of patients with advanced non-small cell lung cancer (NSCLC) treated with second-line pemetrexed or pemetrexed-carboplatin.

  2012cited by this paper
• Genetic Polymorphism of γ-Glutamyl Hydrolase in Chinese Acute Leukemia Children and Identification of a Novel Double Nonsynonymous Mutation

  2012cited by this paper
• Pharmacogenetic Analysis of Pediatric Patients with Acute Lymphoblastic Leukemia: A Possible Association between Survival Rate and ITPA Polymorphism

  2012cited by this paper
• Pharmacogenetic determinants of mercaptopurine disposition in children with acute lymphoblastic leukemia

  2012cited by this paper
• Determinants of mercaptopurine toxicity in paediatric acute lymphoblastic leukemia maintenance therapy.

  2011cited by this paper
• Limitations of extensive TPMT genotyping in the management of azathioprine-induced myelosuppression in IBD patients.

  2011cited by this paper
• Host Pharmacogenetic Factors Significantly Contribute to Refinement of Prognosis in Children with Acute Lymphoblastic Leukemia (ALL): Result From the Malaysia-Singapore (Ma-Spore) ALL 2003 Study

  2011cited by this paper
• Genetic polymorphism of inosine-triphosphate-pyrophosphatase influences mercaptopurine metabolism and toxicity during treatment of acute lymphoblastic leukemia individualized for thiopurine-S-methyl-transferase status

  2010cited by this paper
• Cancer Statistics, 2010

  2010cited by this paper
• Polymorphisms of the gamma-glutamyl hydrolase gene and risk of relapse to acute lymphoblastic leukemia in Mexico.

  2010cited by this paper
• Genetic Polymorphism of Inosine Triphosphate Pyrophosphatase Is a Determinant of Mercaptopurine Metabolism and Toxicity During Treatment for Acute Lymphoblastic Leukemia

  2009cited by this paper
• The Increasing Complexity of Mercaptopurine Pharmacogenomics

  2009cited by this paper
• Pharmacogenomic variations in treatment protocols for childhood acute lymphoblastic leukemia

  2009cited by this paper
• Methylenetetrahydrofolate reductase (MTHFR) C677T and thymidylate synthase promoter (TSER) polymorphisms in Indonesian children with and without leukemia.

  2008cited by this paper
• Acute lymphoblastic leukaemia.

  2008cited by this paper
• Folate pathway genetic polymorphisms and susceptibility of central nervous system tumors in Thai children.

  2008cited by this paper
• Cyclin D1 Pro241Pro (CCND1-G870A) Polymorphism Is Associated with Increased Cancer Risk in Human Populations: A Meta-Analysis

  2008cited by this paper
• Combined effect of CCND1 and COMT polymorphisms and increased breast cancer risk

  2008cited by this paper
• [Pharmacogenomics of acute lymphoblastic leukemia].

  2007cited by this paper
• Genetic polymorphism of C452T (T127I) in human gamma-glutamyl hydrolase in a Japanese population.

  2007cited by this paper
• The low frequency of defective TPMT alleles in Turkish population: A study on pediatric patients with acute lymphoblastic leukemia

  2007cited by this paper
• Genetic Polymorphism of C452T (T127I) in Humanγ-Glutamyl Hydrolase in a Japanese Population(Biopharmacy)

  2007cited by this paper
• Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy

  2006cited by this paper
• Clinical pharmacogenomics of thiopurine S-methyltransferase.

  2006cited by this paper
• Methylenetetrahydrofolate reductase and thymidylate synthase genotypes modify oral mucositis severity following hematopoietic stem cell transplantation

  2006cited by this paper
• Regression Methods in Biostatistics: Linear, Logistic, Survival and Repeated Measures Models

  2006cited by this paper
• Folate cycle gene variants and chemotherapy toxicity in pediatric patients with acute lymphoblastic leukemia.

  2006cited by this paper
• Three novel single nucleotide polymorphisms of the human thiopurine S-methyltransferase gene in Japanese individuals.

  2006cited by this paper
• Pharmacogenomics of acute lymphoblastic leukemia

  2006cited by this paper
• Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia.

  2005cited by this paper
• Effect of polymorphisms in folate-related genes on in vitro methotrexate sensitivity in pediatric acute lymphoblastic leukemia.

  2005cited by this paper
• Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia.

  2005cited by this paper
• Cyclin D1 Gene Polymorphism and Susceptibility to Childhood Acute Lymphoblastic Leukemia in a Chinese Population

  2005cited by this paper
• Moving towards individualized medicine with pharmacogenomics

  2004cited by this paper
• Role of polymorphisms in MTHFR and MTHFD1 genes in the outcome of childhood acute lymphoblastic leukemia

  2004cited by this paper
• Pharmacogenetics of outcome in children with acute lymphoblastic leukemia.

  2004cited by this paper
• Rapid combined genotyping of factor V, prothrombin and methylenetetrahydrofolate reductase single nucleotide polymorphisms using minor groove binding DNA oligonucleotides (MGB probes) and real-time polymerase chain reaction

  2004cited by this paper
• The influence of cyclin D1 (CCND1) 870A>G polymorphism and CCND1-thymidylate synthase (TS) gene-gene interaction on the outcome of childhood acute lymphoblastic leukaemia.

  2003cited by this paper
• Thymidylate synthase gene polymorphism and its association with relapse in childhood B-cell precursor acute lymphoblastic leukemia.

  2003cited by this paper
• Polymorphism of the thymidylate synthase gene and outcome of acute lymphoblastic leukaemia.

  2002cited by this paper
• Methotrexate intracellular disposition in acute lymphoblastic leukemia: a mathematical model of gamma-glutamyl hydrolase activity.

  2002cited by this paper
• Comparison of thymidylate synthase (TS) protein up-regulation after exposure to TS inhibitors in normal and tumor cell lines and tissues.

  2000cited by this paper
• Methotrexate resistance in relapsed childhood acute lymphoblastic leukaemia

  2000cited by this paper
• Novel thymidylate synthase enhancer region alleles in African populations

  2000cited by this paper
• Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker

  2000cited by this paper
• Thiopurine methyltransferase alleles in British and Ghanaian populations.

  1999cited by this paper
• Genotypic and phenotypic analysis of the polymorphic thiopurine S‐methyltransferase gene (TPMT) in a European population

  1998cited by this paper
• Characterization of human cellular gamma-glutamyl hydrolase.

  1998cited by this paper
• Acute lymphoblastic leukaemia.

  1997cited by this paper
• Molecular Diagnosis of Thiopurine S-Methyltransferase Deficiency: Genetic Basis for Azathioprine and Mercaptopurine Intolerance

  1997cited by this paper
• Human thiopurine methyltransferase pharmacogenetics: Gene sequence polymorphisms

  1997cited by this paper
• Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms.

  1996cited by this paper
• Thiopurine Methyltransferase Pharmacogenetics: Human Gene Cloning and Characterization of a Common Polymorphism

  1996cited by this paper
• Higher activity of polymorphic thiopurine S-methyltransferase in erythrocytes from neonates compared to adults.

  1995cited by this paper
• Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemia.

  1994cited by this paper
• Congenital thiopurine methyltransferase deficiency and 6-mercaptopurine toxicity during treatment for acute lymphoblastic leukaemia.

  1993cited by this paper
• Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemia.

  1991cited by this paper
• Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia.

  1990cited by this paper
• Cancer statistics

  1989cited by this paper
• Characteristics of thymidylate synthase purified from a human colon adenocarcinoma.

  1988cited by this paper
• Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity.

  1980cited by this paper

• MTHFR Gene Polymorphisms and Cancer Risk in Children and Adolescents: A Systematic Review and Meta-Analysis

  2025cites this paper
• Association of race/ethnicity with innate immune tumor microenvironment of children with B-acute lymphoblastic leukemia

  2022cites this paper
• Susceptibility to thiopurine toxicity by TPMT and NUDT15 variants in Colombian children with acute lymphoblastic leukemia

  2021cites this paper
• Clinical Implications of Methotrexate Pharmacogenetics in Childhood Acute Lymphoblastic Leukaemia.

  2019cites this paper
• Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for thiopurine dosing based on TPMT and NUDT15 genotypes: 2018 update

  2018cites this paper
• MTHFR polymorphisms in childhood acute lymphoblastic leukemia: influence on methotrexate therapy

  2017cites this paper
• Analysis of Thiopurine S-Methyltransferase Deficient Alleles in Acute Lymphoblastic Leukemia Patients in Mexican Patients.

  2016cites this paper
• Some GCR Polymorphisms (N363S, ER22/23EK, and Bcl-1) May Influence Steroid-induced Toxicities and Survival Rates in Children With ALL

  2016cites this paper
• Paediatric prescribing: why children are not small adults.

  2015cites this paper
• Multiplex pyrosequencing assay using AdvISER-MH-PYRO algorithm: a case for rapid and cost-effective genotyping analysis of prostate cancer risk-associated SNPs

  2015cites this paper